NDC 50090-0267

Pharbetol Regular strength

Acetaminophen

Pharbetol Regular strength is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Acetaminophen.

Product ID50090-0267_0d5f5f20-17ce-4366-a3cd-83a7da5e3016
NDC50090-0267
Product TypeHuman Otc Drug
Proprietary NamePharbetol Regular strength
Generic NameAcetaminophen
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2007-01-09
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart343
Labeler NameA-S Medication Solutions
Substance NameACETAMINOPHEN
Active Ingredient Strength325 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-0267-1

15 TABLET in 1 BOTTLE (50090-0267-1)
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-0267-2 [50090026702]

Pharbetol Regular strength TABLET
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-0267-3 [50090026703]

Pharbetol Regular strength TABLET
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-0267-4 [50090026704]

Pharbetol Regular strength TABLET
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-0267-1 [50090026701]

Pharbetol Regular strength TABLET
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2014-11-28
Marketing End Date2018-12-31

Drug Details

Active Ingredients

IngredientStrength
ACETAMINOPHEN325 mg/1

OpenFDA Data

SPL SET ID:471180ea-1b58-436e-ab7a-ed0b88cc4606
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1298830
  • 313782

    • NDC Crossover Matching brand name "Pharbetol Regular strength" or generic name "Acetaminophen"

    NDCBrand NameGeneric Name
    16103-353Pharbetol Regular strengthPharbetol Regular strength
    50090-0267Pharbetol Regular strengthPharbetol Regular strength
    50090-2156Pharbetol Regular strengthPharbetol Regular strength
    60760-449Pharbetol Regular strengthPharbetol Regular strength
    67046-023Pharbetol Regular strengthPharbetol Regular strength
    0121-0657AcetaminophenAcetaminophen
    0113-7000Basic Care acetaminophenAcetaminophen
    0113-7484basic care acetaminophenAcetaminophen
    0113-7544Basic Care AcetaminophenAcetaminophen
    0113-7130basic care childrens pain and feverAcetaminophen
    0113-0020good sense childrens pain and feverAcetaminophen
    0113-0212Good Sense Childrens Pain and FeverAcetaminophen
    0113-0608good sense childrens pain and feverAcetaminophen
    0113-0998Good Sense Childrens Pain and FeverAcetaminophen
    0113-0161Good Sense pain and feverAcetaminophen
    0113-0397Good Sense Pain and Feveracetaminophen
    0113-0590Good Sense Pain and Feveracetaminophen
    0113-0946good sense pain and feverAcetaminophen
    0113-8959Good Sense Pain and FeverAcetaminophen
    0113-0025Good Sense Pain ReliefAcetaminophen
    0113-0044Good Sense Pain ReliefAcetaminophen
    0113-0187good sense pain reliefAcetaminophen
    0113-0217good sense pain reliefAcetaminophen
    0113-0227Good Sense Pain ReliefAcetaminophen
    0113-0403good sense pain reliefAcetaminophen
    0113-0484Good Sense Pain ReliefAcetaminophen
    0113-0518good sense pain reliefAcetaminophen
    0113-0544good sense pain reliefAcetaminophen
    0113-1889good sense pain reliefacetaminophen
    0113-1975Good Sense Pain ReliefAcetaminophen
    0031-9301Robitussin Direct Sore Throat Painacetaminophen

    Trademark Results [Pharbetol]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PHARBETOL
    PHARBETOL
    78730584 3182003 Dead/Cancelled
    Pharbest Pharmaceuticals Inc.
    2005-10-11
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.